By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

The European Commission has approved Pfizer’s treatment for adults and adolescents with severe hemophilia A or B.

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of ...

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.

Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults.

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.

The partners will work together to make Medable’s digital and decentralized clinical trial platform available on Google Cloud ...

With the rise of technology (and AI), decentralized clinical trials are becoming more popular where some or all of the ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...